arrow
N

Natália Satchiko Hojo-Souza

centro de tecnologia de vacinas
H指数:14
被引数:813

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Comprehensive Stability Assessment of Squalene in a Nanoemulsion Adjuvant and the SpiN-Tec Vaccine: HPLC Quantification, Stress Testing, and Stability Studies

角鲨烯在纳米乳佐剂和SpiN-Tec疫苗中的综合稳定性评估:HPLC定量、应力测试和稳定性研究

2026-09-180
OAAI
Corrigendum to “Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19” [Vaccine 64 (2025) 127756]

更正:“SpiN-Tec,一种基于T细胞的COVID-19 RBD-核衣壳嵌合疫苗的安全性与免疫原性”[Vaccine 64 (2025) 127756]

Vaccine
IF3.5
2026-02-110
OAAI
The LVD/NIAID/NIH MVA1974 clone as an Mpox vaccine – preclinical assessment upon in a model of lethal infection with Orthopoxvirus monkeypox in mice

LVD/NIAID/NIH MVA1974克隆株作为猴痘疫苗——在致死性正痘病毒(猴痘病毒)小鼠感染模型中的预临床评估

Vaccine
IF3.5
2025-10-260
PRE
ASP-2/Trans-sialidase chimeric protein induces robust protective immunity in experimental models of Chagas' disease
2023-05-317
OAAI
Differential requirement of neutralizing antibodies and T cells on protective immunity to SARS-CoV-2 variants of concern
2023-02-139
OAAI
Promotion of neutralizing antibody-independent immunity to wild-type and SARS-CoV-2 variants of concern using an RBD-Nucleocapsid fusion protein
2022-08-1716
OAAI
Protective Immunity against Gamma and Zeta Variants after Inactivated SARS-CoV-2 Virus Immunization
2021-12-046
OAAI